Endocrine and metabolic emergencies: Hypoglycaemia

Therapeutic Advances in Endocrinology and Metabolism

Volumn 2, Issue 2, 2011, Pages 81-93

  Mukherjee, Elora ^a   Carroll, Richard ^b   Matfin, Glenn ^c  

^a EALING HOSPITAL NHS TRUST   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

drug induced hypoglycaemia; hyperinsulinaemia; hypoglycaemia; insulinoma

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALCOHOL; ALPHA GLUCOSIDASE INHIBITOR; ANGIOPEPTIN; C PEPTIDE; DIAZOXIDE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EVEROLIMUS; GLUCAGON; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOCORTICOID; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; INSULIN RECEPTOR ANTIBODY; MEGLITINIDE; METFORMIN; MIGLITOL; OCTREOTIDE; PENTAMIDINE; QUININE; SALICYLIC ACID DERIVATIVE; SULFONYLUREA DERIVATIVE; THIAMINE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ADDISON DISEASE; BLOOD ANALYSIS; BLOOD GLUCOSE MONITORING; BRAIN DYSFUNCTION; CARBOHYDRATE INTAKE; CLINICAL PRACTICE; CRITICAL ILLNESS; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; GROWTH HORMONE DEFICIENCY; HEART ARRHYTHMIA; HORMONE DEFICIENCY; HUMAN; HYPERINSULINEMIA; HYPERTRICHOSIS; HYPOGLYCEMIA; HYPOPITUITARISM; HYPOTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA; KIDNEY FAILURE; KIDNEY FUNCTION TEST; LIVER FAILURE; LIVER FUNCTION TEST; MORTALITY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCYTOPENIA; PATHOPHYSIOLOGY; PATIENT EDUCATION; PERIPHERAL EDEMA; POSTGASTRECTOMY SYNDROME; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; SEPSIS; SURVIVAL RATE; URINALYSIS; VOMITING; WERNICKE ENCEPHALOPATHY;

EID: 79960060573     PISSN: 20420188     EISSN: 20420196     Source Type: Journal    
DOI: 10.1177/2042018811401644     Document Type: Review

References (38)

1. ACCORD Study Group (2008) Effects of intensive glucose lowering in type 2 diabetes. N Eng J Med 358: 2545–2559.
2. American Diabetes Association. (2005) Defining and reporting hypoglycaemia in diabetes. Diabetes Care 28: 1245–1249.
3. American Diabetes Association. (2011) Standards of medical care. Diabetes Care 34(Suppl. 1): S11–S61.
4. Arlt W. (2009) Adrenal insufficiency. Clin Med 8: 211–215.
5. Artavia-Loria E. Chaussain J.L. Bougnères P.F. Job J.C. (1986) Frequency of hypoglycemia in children with adrenal insufficiency. Acta Endocrinologica 113(4 Suppl): S275–S278.
6. Bailey C.J. Day C. (2010) Hypoglycaemia: a limiting factor. Brit J Diab Vasc Dis 10: 2–4.
7. Barnard B. Kline G.A. Service F.J. (2010) Hypoglycaemia following upper gastrointestinal surgery. BMC Gastroenterol 10: 77–81.
8. Basu A. Service F.J. Yu L. (2005) Insulin autoimmunity and hypoglycaemia in seven white patients. Endocr Pract 11: 97–103.
9. BNF. (2011) British National Formulary, 61st edn, British Medical Association and Royal Pharmaceutical Society: London.
10. Clancy T.E. Moore F.D. Jr Zinner M.J. (2006) Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastrointest Surg 10: 1116–1119.
11. Cryer P.E. Axelrod L. Grossman A.B. Heller S.R. Montori V.R. Seaquist E.R. et al (2009) Evaluation and management of adult hypoglycemia; a clinical practice guideline. J Clin Endocrinol Metab 94: 709–728.
12. Diabetes Control and Complications Research Group. (1993) The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 329: 977–986.
13. ENETS guidelines. (2007) Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 84: 183–188.
14. Fisher M. (2010) Hypoglycaemia in patients with type 2 diabetes. Brit J Diab Vasc Dis 10: 35–41.
15. Fletcher, A.A. and Campbell, W.R. (1922) Blood sugar following insulin administration and symptom complex – hypoglycemia. J Metabol Res 2: 637–649.
16. Graveling A.J. Frier B.M. (2010) Does hypoglycaemia cause cardiovascular events? Brit J Diab Vasc Dis 10: 5–12.
17. Hassan Murad M. Coto-Yglesias F. Wang A.T. Sheidaee N. Mullan R.J. Elamin M.B. et al (2009) Drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab 94: 741–745.
18. Heller S. (2008) Minimizing hypoglycaemia while maintaining glycaemic control in diabetes. Diabetes 57: 3177–3183.
19. Krinsley J.S. Keegan M.T. (2010) Hypoglycaemia in the critically ill: how low is too low? Mayo Clin Proc 85: 215–216.
20. Kulke, M.H., Bergsland, E.K. and Yao, J.C. (2009) Glycaemic control in patients with insulinoma treated with Everolimus. N Eng J Med 360 (2): 195–197.
21. Lev-Ran A. Anderson R.W. (1981) The diagnosis of post prandial hypoglycaemia. Diabetes 30: 996–999.
22. Matfin G. (2009) Diabetes and the metabolic syndrome. In: Ed. Porth C.M. Matfin G. (eds). Pathophysiology: Concepts of Altered Health States, 8th, Wolters Kluwer Health: Philadelphia, PA.
23. Mayfroidt G. Keenan D.M. Wang X. Wouters P.J. Veldhuis J.D. van den Berghe G. (2010) Dynamic characteristics of blood glucose time series during course of critical illness. Crit Care Med 38: 1021–1028.
24. NICE-SUGAR Study Investigators. (2009) Intensive versus conventional insulin therapy in critically ill patients. N Engl J Med 360: 1283–1297.
25. Oberg K. Kvols L. Caplin M. Delle Fave G. de Herder W. Rindi G. et al (2004) Consensus report on the use of Somatostatin analogs for the management of neuroendocrine tumours of the gastropancreatic system. Ann Oncol 15: 966–973.
26. Prieto-Sanchez L.M. (2011) Hyperglycaemia in-hospital management. Ther Adv Endocrinol Metab 2: 1–4.
27. Qaseem A. Humphrey L.L. Chou R. Snow V. Shekelle P. et al (2011) Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 154: 260–267.
28. Roberts J. (2010) Antidotes you should know: octreotide for sulfonylurea-induced hypoglycemia. Emergency Med News 32: 10–12.
29. Shrishrimal K. Hart P. Michota F. (2009) Managing diabetes in hemodialysis patients: observations and recommendations. Cleveland Clin J Med 76: 649–655.
30. Tomky D. (2005) Detection, prevention and treatment of hypoglycaemia in the hospital. Diabetes Spectrum 18: 39–44.
31. van den Berghe G. Wouters P. Weekers F. Verwaest C. Bruynickx F. Schetz M. et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345: 1359–1367.
32. Vezzosi D. Bennet A. Courbon F. Caron P. (2008) Short and longterm somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinaemia. Clin Endocrinol 68: 904–911.
33. Vriesendorp T.M. van Santen S. DeVries J.H. de Jonge E. Rosendaal F.R. Schultz M.J. et al (2006) Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 34: 96–101.
34. Waeschle R.M. Moerer O. Hilgers R. Herrmann P. Neumann P. Quintel M. (2008) The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability. Critical Care 12: R129–R129.
35. Weiner R.S. Weiner D.C. Larson R.J. (2008) Benefits and risks of tight glycaemic control in critically ill adults: a meta-analysis. JAMA 300: 933–944.
36. Whipple A.O. (1938) The surgical therapy of hyperinsulinism. J Int Chir 3: 237–276.
37. Yao, J.C., Shah, M.H., Ito, T., Bohas, C.L., Wolin, E.M., van Cutem, E. et al (2011) Everolimus for advanced pancreatic neuroendocrine tumours. N Eng J Med 364 (6): 514–523.
38. Zoungas S. Patal A. Chalmers J. de Galen B.E. Li Q. Billot L. et al (2010) Severe hypoglycaemia and risk of vascular events and death. N Engl J Med 363: 1410–1418.